Director, BD Early Stage

Role: Lead evaluation of early-stage external assets and technologies to guide strategic BD investments from Due Diligence Stage 2 through NBO negotiation. Responsibilities: assess scientific, clinical, regulatory, and commercial evidence; develop investment assessments including valuation and scenario modeling; provide strategic recommendations; partner cross-functionally with R&D, Commercial, Regulatory, and Finance; prepare governance decision materials; and lead capability development within BD. Requirements: Bachelor's in Life Sciences or related; 5-10+ years in pharma/biotech with experience in search & evaluation, early BD, R&D strategy, or product planning; proven ability to influence governance and support investment cases; strong scientific literacy across modalities, and executive communication skills. HighValue: early-stage assets, cross-functional collaboration, global matrix environment, evaluating modalities from discovery to Phase I, and influencing senior-level decisions.